NSEStatement of deviation(s) or variation(s) under Reg. 326d ago · 2 Nov 2026, 05:09 pm

Statement of deviation(s) or variation(s) under Reg. 32

Cineline India Limited · CINELINE

✦ AI SummaryResults

Cineline India Limited has informed the Exchange about a statement of deviation(s) or variation(s) under Reg. 32 for the quarter ended September 30, 2026, stating that there is no deviation(s) or variation(s) in the utilization of proceeds raised through allotment of convertible warrants.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Cineline India Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

Attachments (1)

📄

CINELINE_02112026170835_Statement_of_Deviation.pdf

pdf

Download →
View document text
Date: 2nd November 2026 To, To, BSE Limited, National Stock Exchange of India Limited Department of Corporate Services, Listing Department, Phiroze Jeejeebhoy Towers, Exchange Plaza, C- 1, Block G, Bandra Kurla Dalal Street, Mumbai – 400001 Complex, Bandra (East), Mumbai– 400051 Scrip Code: 532807 Scrip Code: CINELINE Sub: Statement of deviation(s) or variation(s) for the quarter ended September 30, 2026 under regulation 32(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/Ma’am, Pursuant to Regulation 32 of the SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that there is no deviation(s) or variation(s) in the utilization of proceeds raised through allotment of 38,46,153 Equity Shares of face value of ₹5/- each upon conversion/ exchange of/ for equal number of Warrants at an issue price of ₹117 each upon receipt of balance amount at the rate of ₹87.75 per warrant (being 75% of the issue price per warrant as “Warrant Exercise Price”) aggregating to ₹33,74,99,925.75/- A NIL statement of deviation(s) or variation(s), for the aforesaid period, in respect of utilization of proceeds for the Quarter ended September 30, 2026, is duly reviewed by the Audit Committee of the Company and the same is enclosed with this letter. Kindly take the same on your records. For Cineline India Limited Mr. Rasesh Kanakia Chairman & Whole Time Director DIN:00015857 Encl.: As Above Cineline India Limited 2nd Floor, A & B wing, Vilco Centre, Subhash Road, Opp Garware, Vile Parle (E), Mumbai- 400057 (India) Tel: 91-22-67266688, email: investor@cineline.co.in, Corporate Identity Number (CIN): L92142MH2002PLC135964, www.moviemax.co.in Statement of deviation/ variation in utilization of funds raised: Particulars Details Name of listed entity Cineline India Limited Mode of fund raising Preferential Issue of Convertible Warrants Amount raised (Rs. in Crore) 4499.99 Lakhs Report filed for quarter ended 30th September, 2026 Monitoring Agency Not Applicable Monitoring Agency Name, if applicable Not Applicable Is there a deviation/ variation in use of No funds raised If Yes, whether the same is pursuant to Not Applicable change in terms of contracts or objects which was approved by the shareholders If yes, date of shareholders’ Approval Not Applicable Explanation for the deviation/ variation Not Applicable Comments of the audit committee Nil after review Comments of the auditors, if any Nil Objects for which funds have been raised and where there has been a deviation/ variation, in the following table: Not Applicable Original Modified Original Modified Funds Amount of Remarks, object object, allocation allocation, Utilized deviation/ if any if any if any variation for the quarter according applicable object (in Rs. crore and in %) Issue NA 4499.99 NA 3832.96 0 - proceeds Lakhs Lakhs shall be utilized to meet the funding requirements for the Cineline India Limited 2nd Floor, A & B wing, Vilco Centre, Subhash Road, Opp Garware, Vile Parle (E), Mumbai- 400057 (India) Tel: 91-22-67266688, email: investor@cineline.co.in, Corporate Identity Number (CIN): L92142MH2002PLC135964, www.moviemax.co.in growth in the business of Company, general corporate purposes and the working capital requirements Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc. Thanks & Regards, For Cineline India Limited Mr. Rasesh Kanakia Chairman & Whole Time Director DIN:00015857 Cineline India Limited 2nd Floor, A & B wing, Vilco Centre, Subhash Road, Opp Garware, Vile Parle (E), Mumbai- 400057 (India) Tel: 91-22-67266688, email: investor@cineline.co.in, Corporate Identity Number (CIN): L92142MH2002PLC135964, www.moviemax.co.in